which glp-1 medication is best for weight loss Researchers move closer to matching patients with drug that works them GLP-1 analogs, new trend in

Curr Obes Rep 12 , 6174 (2023)

However, many of these drugs were associated with unexpected adverse effects, such as nausea, aversion, valvular heart disease, and even suicidal tendencies, leading to the discontinuation of most of their development

But unlike natural GLP-1, which decays very rapidly (its half-life is just 2 minutes), synthetic GLP-1 receptor agonists are long-acting and remain active in your body for hours or days

Patients with the following characteristics often see the strongest improvements: Rheumatoid arthritis Psoriatic arthritis Osteoarthritis of the knees or hips Obesity or insulin resistance Chronic fatigue Long-term steroid use Difficulty losing weight despite trying Who Should Avoid GLP-1

While off-label prescribing is a common practice and one allowed by the FDA the deliberate promotion of drugs for unapproved uses can be construed as prioritizing market expansion over patient welfare

Centers for Disease Control and Prevention, CDC Extended BMI-for-age Growth Charts, National Center for Health Statistics (2024)